Insider files 10b5-1 sales for 16,667 shares

Company filings show proposed insider sales under Rule 144.

Rhea-AI Filing Summary

Company filings show proposed insider sales under Rule 144. The excerpt lists scheduled 10b5-1 sales by Beth Hecht of 16,667 shares on 05/01/2026 and 06/01/2026, with gross proceeds reported as $103,805.37 and $100,982.35 respectively. The filing also lists prior acquisitions including 37,409 RSUs (01/31/2023), 10,026 ESPP shares (06/30/2020), and 2,563 open-market purchases (03/13/2020).

Insights

Securities Compliance Counsel

Routine Rule 144 notice documents pre-arranged insider sales under 10b5-1.

The filing lists two scheduled 10b5-1 dispositions by Beth Hecht for 16,667 shares on 05/01/2026 and 06/01/2026. Each sale shows a specific gross amount in dollars.

These entries are procedural notices required for certain insider transactions; cash‑flow treatment and whether sales occur exactly as scheduled depend on plan execution and market conditions.

Key Figures

Scheduled sale: 16,667 shares Scheduled sale: 16,667 shares Gross proceeds: $103,805.37 +4 more

7 metrics

Scheduled sale 16,667 shares Sale on 05/01/2026

Scheduled sale 16,667 shares Sale on 06/01/2026

Gross proceeds $103,805.37 Sale dated 05/01/2026

Gross proceeds $100,982.35 Sale dated 06/01/2026

Restricted Stock Units 37,409 shares 01/31/2023

ESPP shares 10,026 shares 06/30/2020

Open-market purchases 2,563 shares 03/13/2020

Key Terms

10b5-1, Restricted Stock Units, Employee Stock Purchase Plan

3 terms

10b5-1 regulatory

"10b5-1 Sales for BETH HECHT 1375 West Fulton Street"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 37,409 | 01/31/2023"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Employee Stock Purchase Plan financial

"Employee Stock Purchase Plan | Issuer | 10,026 | 06/30/2020"

An employee stock purchase plan is a company program that lets workers buy shares through small payroll deductions, often at a discount to the market price and after a set offering period. Think of it like a workplace savings plan that turns into ownership: it encourages employees to share in the company’s success and can create predictable buying or selling of stock that investors watch because it affects supply, demand and employee incentives.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the XERS Form 144 disclose about insider sales?

The filing discloses two scheduled 10b5-1 sales by Beth Hecht of 16,667 shares each on 05/01/2026 and 06/01/2026, with reported gross proceeds of $103,805.37 and $100,982.35 respectively.

Who is executing the sales reported in the XERS excerpt?

The sales are reported as 10b5-1 plan transactions for Beth Hecht. The excerpt lists her address and identifies the disposition method as 10b5-1 sales on the stated dates.

What prior holdings or acquisitions are shown in the filing excerpt?

The excerpt lists holdings/acquisitions including 37,409 Restricted Stock Units dated 01/31/2023, 10,026 ESPP shares dated 06/30/2020, and 2,563 open-market purchases dated 03/13/2020.

Does the excerpt state who receives the sale proceeds?

The excerpt provides gross dollar amounts for the scheduled sales but does not state the recipient of proceeds beyond the reported sale amounts; cash‑flow treatment is not detailed in the provided text.

Are the reported sales automatic or discretionary?

The sales are identified as 10b5-1 plan transactions, which indicates they are scheduled under a pre-arranged plan; the excerpt does not include plan adoption dates or additional plan terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 04:51 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001652410
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	XERIS BIOPHARMA HOLDINGS, INC.
SEC File Number	001-40880
Address of Issuer	1375 West Fulton Street, Suite 1300 Chicago ILLINOIS 60607
Phone	8444455704
Name of Person for Whose Account the Securities are To Be Sold	BETH HECHT
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	49998	395984.16	172642055	07/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/31/2023	Restricted Stock Units	Issuer			37409	01/31/2023	N/A
Common	06/30/2020	Employee Stock Purchase Plan	Issuer			10026	06/30/2020	Cash
Common	03/13/2020	Open Market Purchase	Issuer			2563	03/13/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for BETH HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	06/01/2026	16667	100982.35
10b5-1 Sales for BETH HECHT 1375 West Fulton Street, Suite 1300 Chicago IL 60607	Common	05/01/2026	16667	103805.37

144: Remarks and Signature

Remarks	The 10,026 securities to be sold were acquired upon the acquisition of employee stock purchase plan shares during the period of 06/30/2020 through 06/30/2024.
Date of Notice	07/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Beth Hecht
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)